Original news and analysis on international IP policy
The United Nations Development Programme (UNDP) has launched a joint initiative with Impact Hub, an international community of social entrepreneurs. The initiative is a platform named "#Accelerate2030," aiming at supporting and promoting the most promising impact-driven ventures focusing on the UN Sustainable Developments Goals (SDGs).
DURBAN, South Africa - The international medical humanitarian organisation Médecins Sans Frontières (MSF) has found that prices of older HIV drugs continue to decline, but newer drugs largely remain expensive.
NAIROBI, Kenya (IP-Watch) - A commitment signed this week to facilitate investment in Africa’s pharmaceutical industry is expected to boost the sector’s production and make available essential medicines for millions of needy people.
NAIROBI, Kenya (IP-Watch) -- A global database on non-tariff measures (NTMs) has been launched here at the 14th United Nations Conference on Trade and Development (UNCTAD 14). Also this week the World Investment Forum kicked off, the first such event since agreement of the UN Sustainable Development Goals.
NAIROBI, Kenya (IP-Watch) – The United Nations Conference on Trade and Development (UNCTAD) 14th Session opened here yesterday, with leaders calling for deeper and broader cooperation between trade and development.
Populism is in vogue these days and critics of pharmaceutical patents are trying to ride the wave, claiming that undermining patents will dramatically decrease prices but not reduce innovation. Both sides of that claim are flawed, writes Steven Tepp.
A new book provides ways for public research to avoid legal battles over genetic resources in the fields of agriculture, biomedicine, environmental management and microbiology by making best use of an international protocol on access to genetic resources and benefit-sharing.
A resolution on access to medicines proposed by a number of developing countries was adopted today by the United Nations Human Rights Council, as well as a resolution on enhancing capacity-building in public health. This marks yet another United Nations fora in which developing countries seek to raise the issue of access to medicines, particularly with regard to high prices.
A top Ecuadoran official said today at the United Nations in Geneva that WikiLeaks founder Julian Assange’s health is deteriorating after four years confined in the Ecuadoran embassy in London, while the United Kingdom and Sweden are ignoring the findings of the UN Working Group on Arbitrary Detention which called for Assange’s release. The Ecuadoran Minister of Foreign Affairs also said Ecuador will carry on issuing compulsory licences for medicines as it sees fit, underlining the increasing role of intellectual property and the greater privatisation of knowledge.
Britons' 23 June decision to pull out of the European Union has caused shock waves in the UK and Europe, and the vote is still being digested. Early reactions from members of the intellectual property community show that the impact of Brexit on IP policies and issues in Britain and Europe is far from clear.
A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
Movement has been happening in international organisations in recent weeks, particularly in United Nations agencies, as new executive directors were nominated, and department directorships changed hands. The private sector and non-governmental organisations also saw a number of position switches and nominations, in particular in the health sector. Law offices kept pace with the usual chair revolving.